会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Pharmaceutical containing PPAR delta agonist
    • 含有PPARδ激动剂的药物
    • US08802705B2
    • 2014-08-12
    • US12451564
    • 2008-05-20
    • Yoshikuni NakamuraIkuko HananoJun Inoue
    • Yoshikuni NakamuraIkuko HananoJun Inoue
    • A61K31/422A61K31/427
    • A61K31/427A61K31/421A61K31/426C07D263/32C07D277/24C07D417/06
    • Provision of an agent for promoting proliferation of meibomian gland epithelial cells or corneal epithelial cells, and a therapeutic agent for ocular diseases such as meibomian gland dysfunction, dry eye and the like.A preparation containing [3-[2-[4-isopropyl-2-(4-trifluoromethyl)phenyl-5-thiazolyl]ethyl]-5-methyl-1,2-benzisoxazol-6-yl]oxyacetic acid, [4-[3-[2-(4-trifluoromethyl)phenyl-4-isopropyl-5-thiazolyl]propionyl]-2-methylphenoxy]acetic acid or [4-[3-[2-(2-hydroxy-4-chlorophenyl)-5-isopropyl-4-oxazolyl]propionyl]-2-methylphenoxy]acetic acid, or a pharmacologically acceptable salt thereof as an active ingredient is used as an agent for promoting proliferation of meibomian gland epithelial cells or corneal epithelial cells, as well as a therapeutic agent for ocular diseases such as meibomian gland dysfunction, dry eye and the like.
    • 提供用于促进睑板腺上皮细胞或角膜上皮细胞增殖的药剂,以及眼部疾病如睑板腺功能障碍,干眼症等的治疗剂。 含有[3- [2- [4-异丙基-2-(4-三氟甲基)苯基-5-噻唑基]乙基] -5-甲基-1,2-苯并异恶唑-6-基]氧基乙酸[4- [3- [2-(4-三氟甲基)苯基-4-异丙基-5-噻唑基]丙酰] -2-甲基苯氧基]乙酸或[4- [3- [2-(2-羟基-4-氯苯基) 5-异丙基-4-恶唑基]丙酰基] -2-甲基苯氧基]乙酸或其药理学上可接受的盐作为活性成分用作促进睑板腺上皮细胞或角膜上皮细胞增殖的试剂,以及 诸如睑板腺功能障碍,干眼症等眼部疾病的治疗剂。
    • 7. 发明授权
    • Optical signal transmission device
    • 光信号传输装置
    • US07228073B2
    • 2007-06-05
    • US10615394
    • 2003-07-09
    • Jun InoueHideyuki SotobayashiWataru ChujoHitoshi Kawaguchi
    • Jun InoueHideyuki SotobayashiWataru ChujoHitoshi Kawaguchi
    • H04J4/00H04J14/08H04B10/08
    • H04J14/08
    • An optical signal transmission device for transmitting phase information of optical signals is provided. The device includes a multiplexing formatted optical signal generator arranged to generate multiplexing formatted optical signals. The device also includes an optical phase generator arranged to receive the multiplexing formatted optical signals. An optical information transmission method for transmitting optical signal information including phase information is also provided. The method includes receiving multiplexing formatted optical signals generated by a multiplexing formatted optical signal generator at an optical phase generator. The method also includes phase conjugating the multiplexing formatted optical signals by means of four wave mixing (FWM).
    • 提供一种用于发送光信号的相位信息的光信号传输装置。 该设备包括多路复用格式化的光信号发生器,被布置为产生复用格式化的光信号。 该装置还包括光学相位发生器,其布置成接收复用格式化的光信号。 还提供了一种用于发送包括相位信息的光信号信息的光信息传输方法。 该方法包括在光相位发生器处接收由复用格式化的光信号发生器产生的格式化的光信号复用。 该方法还包括通过四波混频(FWM)将复用格式化的光信号相位共轭。
    • 9. 发明授权
    • Angiogenesis inhibitor
    • 血管生成抑制剂
    • US06214800B1
    • 2001-04-10
    • US09282501
    • 1999-04-09
    • Chiho FukiageMitsuyoshi AzumaJun InoueMasayuki NakamuraYuka Yoshida
    • Chiho FukiageMitsuyoshi AzumaJun InoueMasayuki NakamuraYuka Yoshida
    • A61K3800
    • A61K38/55C07C311/19C07D303/48
    • An angiogenesis inhibitor comprising a cysteine protease inhibitory compound. As the preferable cysteine protease inhibitory compound, epoxysuccinic acid compounds, peptide halohydrazide compounds, calpain inhibitory compounds, compounds of the formula (I) and compounds of the formula (VI) can be used. The angiogenesis inhibitor of the present invention suppresses new formation of blood vessels in the living tissues, so that it can be used as a superior therapeutic or prophylactic agent of angiogenesis associated with wound healing, inflammation, growth of tumor and the like; and angiogenesis as seen in diabetic retinopathy, prematurity retinopathy, retinal venous occlusion, senile discoid macular degeneration and the like, as well as for prevention of metastasis of tumors.
    • 一种包含半胱氨酸蛋白酶抑制化合物的血管生成抑制剂。 作为优选的半胱氨酸蛋白酶抑制化合物,可以使用环氧琥珀酸化合物,肽卤代酰肼化合物,钙蛋白酶抑制化合物,式(I)的化合物和式(VI)的化合物。 本发明的血管发生抑制剂抑制活组织中血管的新形成,可以用作与伤口愈合,炎症,肿瘤生长等有关的血管生成的优异治疗或预防剂。 和血管生成,如糖尿病视网膜病变,早产儿视网膜病变,视网膜静脉闭塞,老年性盘状黄斑变性等,以及用于预防肿瘤转移。